Rankings/Regard
Regard logo

Regard

NativeAI NativePrivateUpdated November 15, 2026

The clinical decision support AI that is quietly reducing diagnostic errors in hospitals.

Website
regard.com
Founded
2017
CEO
Eli Ben-Joseph
HQ
Los Angeles, CA, United States
Stage
Private
Revenue
Not disclosed
Total Funding
$84M
Employees
201-500
Flag a data issue
Healthcare ToolsHealthcare
31.6Bluescore
Momentum69.1
Market MapEarly Stage
Rank change (7d)▼ 13

Executive Summary

Updated Nov 12, 2026

What they do

  • Reads the entire EHR chart to recommend diagnoses for inpatient clinicians
  • Drafts proactive clinical notes before encounters, built around accurate diagnoses
  • Supports CDI, screening and mid-revenue-cycle workflows from one clinical platform

Why it matters

  • Catches missed diagnoses that busy clinicians skip because they lack time to read charts
  • Captures documentation at the point of care, cutting retrospective CDI queries and denials
  • Company reports more than $50M in earned revenue unlocked for health system partners

Best fit

  • Large acute-care health systems seeking diagnostic accuracy and documentation integrity together
  • CDI and revenue-cycle leaders tired of chasing charts after discharge
  • Hospitals using Microsoft Dragon Copilot who want diagnostic insights added to ambient documentation

Watch-outs

  • Revenue-capture positioning may draw payer and compliance scrutiny over coding intensity
  • Coverage is mainly inpatient; specialty expansion to cardiology and surgery is recent
  • Public funding record ends with a 2024 Series B, so check the runway

Products & Offerings

Regard Clinical Notes (Proactive Documentation)

Gives clinicians the relevant chart data before an encounter, combines it with patient-physician conversation, recommends diagnoses and drafts a comprehensive note within the EHR.

PlatformEnterpriseFlagship2025

Regard Mid-Revenue Cycle / CDI

Captures complete diagnoses and clinical complexity at the point of care, supporting CDI review, utilization review, discharge planning and denial appeals.

EnterpriseEnterpriseLive

Regard Screening

Reviews structured and unstructured data across all hospital patients to find people eligible for care interventions, along with quality gaps that keyword filters miss.

EnterpriseEnterpriseEmerging

Regard for Microsoft Dragon Copilot

Integration that pairs Dragon Copilot's voice dictation and ambient listening with Regard's real-time diagnostic insights drawn from the full EHR.

PlatformEnterpriseEmerging2025

Latest News

Analyst VerdictEvaluate

Updated Nov 12, 2026

Regard is a credible inpatient clinical AI vendor with real enterprise traction. Banner Health is rolling it out across all 33 of its acute-care hospitals, Cedars-Sinai is deploying it at two hospitals, and a Microsoft Dragon Copilot collaboration widens its reach. Health systems weighing AI for diagnosis capture and CDI should run a structured evaluation with clear metrics: diagnostic accuracy, how many suggestions physicians accept, fewer CDI queries, and audit-ready revenue impact. Compare it against EHR-native and CDI-incumbent alternatives before committing to a multi-year deal.

Signal Provenance

Latest observation date and source for each signal category

Signal CategoryLast UpdatedSource
Funding Signals
Last funding round, Funding stage
Nov 10, 2026Cited web research
Hiring Velocity
Headcount, Headcount growth
Nov 15, 2026Research agents (estimate)
Technical Output
Research papers, GitHub activity
Nov 15, 2026Hugging Face Hub + news feed + research agents
News Sentiment
News mentions, News sentiment
Nov 15, 2026Verified news feed
Partnership Signals
Enterprise partnerships, Distribution partners
Nov 15, 2026Research agents (estimate)
Revenue Indicators
ARR estimate, Revenue growth
Nov 15, 2026Research agents (estimate)
Leadership Signals
CEO tenure, Founder-led
Oct 19, 2026Research agents (estimate)
Competitive Position
Category rank, Market share
Oct 18, 2026Research agents (estimate)

Why this Bluescore?

6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology

Regard's Bluescore of 31.6 rests most on Customer Adoption (5.2, 50th percentile). Its weakest area is Product Depth (1.5, 1st percentile).

In plain English

Regard's Bluescore of 31.6 out of 100 is held back mainly by Product Depth, which scored 1.5 of 10 and sits at the 1st percentile among the AI250, and by Talent & Research, which scored 2.1 of 10 and sits at the 4th percentile. Its strongest areas are Business Model & Revenue at 4.4 of 10 (45th percentile) and Customer Adoption at 5.2 of 10 (50th percentile), which added 9.2 and 6.8 points. Product Depth carries a 21% weight and still has 17.9 points left to gain, so improving it would move the Bluescore more than anything else, and the company currently ranks #248 of 247 overall, down 4 places since yesterday.

Written by AI from the scores below and checked against them; updated nightly.

D1 · Business Model & Revenue (21%)
4.4
+9.2 of 21 pts · 45th pct
D2 · Product Depth (21%)
1.5
+3.2 of 21 pts · 1st pct
D3 · Data & Model Moat (19%)
3.5
+6.6 of 19 pts · 22nd pct
D4 · Talent & Research (16%)
2.1
+3.4 of 16 pts · 4th pct
D5 · Customer Adoption (13%)
5.2
+6.8 of 13 pts · 50th pct
D6 · Investment Momentum (10%)
2.5
+2.5 of 10 pts · 16th pct

Risks

Updated Nov 12, 2026

Diagnosis-driven revenue uplift could trigger payer audits or upcoding compliance concerns
High
EHR vendors and ambient AI platforms could bundle competing diagnostic-documentation features
Medium
Wrong diagnostic suggestions could cause patient-safety or liability exposure if accepted uncritically
Medium
Private Series B company with about 130 staff may strain multi-system rollouts
Medium
Specialty coverage beyond hospital medicine is new and lightly proven at scale
Low
Feedback